Clinical Trial Update: Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction [Phase 1]

View source ↗

Summary

A Phase I trial evaluated daily RAD001 (everolimus) in combination with mitomycin C in patients with advanced gastric cancer and advanced cancer of the esophago…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of the Esophagogastric Junction
• Gastric Cancer

Drugs mentioned

• Mitomycin-C (mitomycin C)
• RAD001 (everolimus)

Snippet

Sponsor: Krankenhaus Nordwest | Conditions: Advanced Gastric Cancer, Advanced Cancer of the Esophagogastric Junction | Phase 1 | Status: COMPLETED